Danish drugmaker Novo Nordisk taps OpenAI in drug R&D
The deal builds on staff access to a custom version of ChatGPT to help scientists identify drug targ[……] Read More
The deal builds on staff access to a custom version of ChatGPT to help scientists identify drug targ[……] Read More